Sanofi India · NSE: SANOFI · BSE: 500674
Q3 FY22 results · Oct–Dec 2021
Sanofi India reported revenue from operations of ₹687.90 crore (down 4.5% from Q3 FY21) and net profit of ₹90.40 crore (down 26.5% from Q3 FY21) for Q3 FY22 (Oct–Dec 2021), on a standalone basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 687.90 | 720.30 | −4.5% | 754.50 | −8.8% |
| Other income | 16.30 | 16.20 | +0.6% | 14.70 | +10.9% |
| Total income | 704.20 | 736.50 | −4.4% | 769.20 | −8.5% |
| Profit before tax | 132.20 | 170.20 | −22.3% | 687.90 | −80.8% |
| Net profit for the period | 90.40 | 123.00 | −26.5% | 529.80 | −82.9% |
| EPS, basic (₹) | 39.25 | 53.41 | −26.5% | 230.04 | −82.9% |
| Net margin (%) | 13.1 | 17.1 | 70.2 |
Standalone
- Filed with BSE
- 24 Feb 2022, 16:15 IST
- Board meeting
- 23 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Audited
- Source
- XBRL filing on BSE